US58933Y1055
US58933Y1055
Merck & Company, Inc.
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 62/100, minimal insolvency risk). The high overall score (6/7) is driven primarily by extreme stock price swings (±24.7% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
6/7 High
6 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.2x).
Beta (Market Relation)
0.22x
DefensiveVolatility (5Y p.a.)
24.7% p.a.
5-Year HorizonMax Drawdown (5Y)
-44.7%
5-Year HorizonSharpe Ratio
0.39
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +64.8% |
| 3 Years | 26.5% | -44.7% | 0.32 | +10.9% |
| 5 Years | 24.7% | -44.7% | 0.39 | +12% |
| 10 Years | 23.4% | -44.7% | 0.27 | +8.9% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 High valuation risk: Avg P/E of 115.6 (Elevated multiple compression risk)
Historical Stress Test: Maximum peak-to-trough drawdown of -44.7% in the extended horizon.